SEMA7A Antibodies

Santa Cruz Biotechnology offers a broad range of SEMA7A monoclonal antibodies for investigating SEMA7A's role in various biological processes. SEMA7A monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SEMA7A, or Semaphorin 7A, plays a crucial role in cell signaling, influencing processes such as neuronal development, immune response, and cell adhesion. SEMA7A's function in axon guidance and synaptic plasticity highlights its significance in neurobiology. The involvement of SEMA7A in immune cell regulation makes it a key target for studies related to inflammation and autoimmune diseases. Research focused on SEMA7A can provide valuable insights into various pathologies, including cancer and neurological disorders. Investigating SEMA7A expression patterns helps researchers understand cellular communication pathways and their impact on disease progression. SEMA7A research continues to reveal new aspects of cellular development and immune system function. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SEMA7A's role in health and disease.